ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiac Computarized Tomography in Infective Endocarditis (cardiac CT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00550823
Recruitment Status : Unknown
Verified October 2007 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : October 30, 2007
Last Update Posted : October 30, 2007
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center

Brief Summary:
The diagnosis of infective endocarditis is based on the results of blood culture and findings on transeosophageal echocardiography. Cardiac computarized tomography is a new modality, mainly used for the imaging of coronary arteries. Its use in the diagnosis of infective endocarditis is not well known.The purpose of this study is to establish the use of cardiac CT in infective endocarditis.

Condition or disease Intervention/treatment Phase
Infective Endocarditis Device: Cardiac CT 0BRILLIANT 64 Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: The Use of Cardiac Computarized Tomography in Infective Endocarditis
Study Start Date : November 2007
Estimated Study Completion Date : November 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endocarditis
U.S. FDA Resources

Arm Intervention/treatment
Experimental: A,1 Device: Cardiac CT 0BRILLIANT 64
Cardiac CT



Primary Outcome Measures :
  1. The diagnostic capacity of cardiac CT in comparison with TEE in the diagnosis of infective endocarditis [ Time Frame: 1 year ]

Secondary Outcome Measures :
  1. Assessment of cardiac function in patients with infective endocarditis [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients diagnosed with infective endocarditis

Exclusion Criteria:

  • Allergy to contrast agent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00550823


Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Principal Investigator: Ori Elkayam, M.D Tel Aviv Medical Center

ClinicalTrials.gov Identifier: NCT00550823     History of Changes
Other Study ID Numbers: 362-07
First Posted: October 30, 2007    Key Record Dates
Last Update Posted: October 30, 2007
Last Verified: October 2007

Additional relevant MeSH terms:
Endocarditis
Endocarditis, Bacterial
Heart Diseases
Cardiovascular Diseases
Bacterial Infections
Cardiovascular Infections
Infection